Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry F Uretsky

Showing results (141-150 of 225) with videos related to

Pageof 23
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 7, 2022
Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) ProgramSrikanth Vallurupalli, Edward Hess, Mary E Plomondon, et al.
JACC. Cardiovascular Interventions|November 10, 2022
Trans-Stent FFR Gradient as a Modifiable Integrant in Predicting Long-Term Target Vessel FailureBarry F Uretsky, Shiv Kumar Agarwal, Srikanth Vallurupalli, et al.
Anesthesiology|September 10, 2002
Cardiac arrest on induction of anesthesia due to triple vessel coronary artery disease despite a "Negative" angiogramRashmi N Mueller, Barry F Uretsky, Lei Hao, et al.
Journal of the American Heart Association|February 5, 2020
Prospective Evaluation of the Strategy of Functionally Optimized Coronary InterventionBarry F Uretsky, Shiv K Agarwal, Srikanth Vallurupalli, et al.
Journal of the American College of Cardiology|March 19, 2002
Clinical benefits of low serum digoxin concentrations in heart failureKirkwood F Adams, Mihai Gheorghiade, Barry F Uretsky, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 11, 2006
Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactionsYumei Ye, Yu Lin, Shaul Atar, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 2, 2013
Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: Comprehensive systematic review and meta-analysis of randomized controlled trialsAbdul Hakeem, Konstantinos Marmagkiolis, Yalcin Hacioglu, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 18, 2017
Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of "vessel architecture"Lorenzo Azzalini, Mauro Carlino, Emmanouil S Brilakis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 productionYumei Ye, Yu Lin, Jose R Perez-Polo, et al.
Journal of Translational Medicine|September 20, 2014
AAV2/8-hSMAD3 gene delivery attenuates aortic atherogenesis, enhances Th2 response without fibrosis, in LDLR-KO mice on high cholesterol dietHongqing Zhu, Maohua Cao, Jose A Figueroa, et al.
Pageof 23

Showing results (141-150 of 225) with videos related to

Sort By:
Pageof 23
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 7, 2022
Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) ProgramSrikanth Vallurupalli, Edward Hess, Mary E Plomondon, et al.
JACC. Cardiovascular Interventions|November 10, 2022
Trans-Stent FFR Gradient as a Modifiable Integrant in Predicting Long-Term Target Vessel FailureBarry F Uretsky, Shiv Kumar Agarwal, Srikanth Vallurupalli, et al.
Anesthesiology|September 10, 2002
Cardiac arrest on induction of anesthesia due to triple vessel coronary artery disease despite a "Negative" angiogramRashmi N Mueller, Barry F Uretsky, Lei Hao, et al.
Journal of the American Heart Association|February 5, 2020
Prospective Evaluation of the Strategy of Functionally Optimized Coronary InterventionBarry F Uretsky, Shiv K Agarwal, Srikanth Vallurupalli, et al.
Journal of the American College of Cardiology|March 19, 2002
Clinical benefits of low serum digoxin concentrations in heart failureKirkwood F Adams, Mihai Gheorghiade, Barry F Uretsky, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 11, 2006
Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactionsYumei Ye, Yu Lin, Shaul Atar, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 2, 2013
Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: Comprehensive systematic review and meta-analysis of randomized controlled trialsAbdul Hakeem, Konstantinos Marmagkiolis, Yalcin Hacioglu, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 18, 2017
Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of "vessel architecture"Lorenzo Azzalini, Mauro Carlino, Emmanouil S Brilakis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 productionYumei Ye, Yu Lin, Jose R Perez-Polo, et al.
Journal of Translational Medicine|September 20, 2014
AAV2/8-hSMAD3 gene delivery attenuates aortic atherogenesis, enhances Th2 response without fibrosis, in LDLR-KO mice on high cholesterol dietHongqing Zhu, Maohua Cao, Jose A Figueroa, et al.
Pageof 23